compound introduction
GSK1820795A, as a telmisartan analog, is a selective hGPR132a antagonist. GSK1820795A blocks activation of yeast cells expressing hGPR132a by N-acylamides GSK1820795A is also a angiotensin II antagonists and partial PPARγ agonists (compound 38) . In Vitro GSK1820795A blocks responses of yeast expressing hGPR132a to agonists NPGly, NLGly, linoleamide, and SB-583831. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:AT1 Receptor 0.006 μM (IC 50 ) hPPARγ 0.25 μM (EC 50 ) mouse PPARγ 0.27 μM (EC 50 )
